JLP-10975-88938
4 vaccinations
5 coded responses
53 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 974 / OR
- Registered
- 2021-02-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
ZSK-19242-77814
Child or adolescent in my care · Female · 2022-06-25
7Z8-29477-30427
Child or adolescent in my care · Male · 2022-06-25
Timeline
-
2021-02-05
Registered in v-safe
-
2021-02-05
Dose 1 — Moderna
-
2021-02-05
Health check-in — 0 day, dose 1Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-05
Report sent to call center — 0 day, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-02-06
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-02-07
- 2021-02-08
- 2021-02-09
-
2021-02-10
Survey response — days 1–6 daily, dose 1MedDRA: Abortion spontaneous — Feeling: Fair · HeadacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-02-11
- 2021-02-12
- 2021-02-19
- 2021-02-26
-
2021-03-05
Dose 2 — Moderna
-
2021-03-05
Survey response — 0 day, dose 2MedDRA: Dyspnoea — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-03-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2021-03-08
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-09
Survey response — days 1–6 daily, dose 2MedDRA: Inflammation — Feeling: Good · Muscle or body aches, Fatigue or tirednessMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-03-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-11
- 2021-03-12
- 2021-03-19
- 2021-03-26
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-06-04
- 2021-09-05
-
2021-11-02
Dose 3 — Moderna
- 2021-11-02
-
2021-11-03
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-11-04
- 2021-11-05
- 2021-11-06
- 2021-11-07
- 2021-11-08
- 2021-11-09
- 2021-11-16
- 2021-11-23
- 2021-11-30
- 2021-12-07
- 2021-12-14
- 2022-02-01
-
2022-05-03
Survey response — 6 month, dose 3MedDRA: Hypoglycaemia, Postprandial hypoglycaemia — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11 · check-in answers available
-
2022-09-10
Dose 4 — Pfizer-BioNTech
-
2022-09-10
Health check-in — 0 day, dose 4Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-09-11
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
-
2022-09-12
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal painAdult check-in
-
2022-09-13
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-09-14
Health check-in — days 1–6 daily, dose 4Feeling: Good · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal painAdult check-in
-
2022-09-17
Health check-in — 7 day, dose 4Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-09-24
- 2022-10-01
- 2022-10-08
- 2022-10-15
- 2022-10-22
- 2022-12-10
-
2023-03-12
Survey response — 6 month, dose 4MedDRA: Migraine — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11 · check-in answers available
-
2023-03-12
Report sent to call center — 6 month, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-03-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-05 | Moderna | |
| 2 | 2021-03-05 | Moderna | |
| 3 | 2021-11-02 | Moderna | No |
| 4 | 2022-09-10 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-02-05 | priority 2/3 | |
| 2023-03-12 | Unsuccessful |
Free text
Release 4
Systemic reaction (other): Miscarriage
Release 5
Systemic reaction (other): Difficulty breathing
Systemic reaction (other): Inflammation
Release 11
Symptoms: Hypoglycemic episodes including reactive hypoglycemia
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hypoglycaemia | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Postprandial hypoglycaemia | · | · | ✓ |
| SRO | Abortion spontaneous | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Inflammation | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release